TACTIC THAT'S 'POISON' TO BIDS
Wall Street's ''poison pills'' appear to be deadly medicine - even though no company has actually had to swallow one yet. The poison pill is an increasingly popular defense against takeovers. Though it can take different forms, the basic strategy involves a company giving its stockholders the right to buy shares at a special price, or get other benefits, when a hostile bidder tries to take over the company - making such a takeover prohibitively expensive, or ''poisonous,'' for the would-be acquirer. The defense, and the phrase, emerged in the course of Lenox Inc.'s 1983 battle to fend off a takeover by the Brown-Forman Distillers Corporation - although Lenox ultimately decided to dissolve its pill and accept a bid from Brown-Forman. Still, most takeover experts see the poison pill as a perfectly effective preventative: No company that has adopted the pill has ever had to use it.
